Everyday Relationships Can Connect Older People's Lives

Published Date: 08 Mar 2023

A positive relationship between social interaction and survival was detected regardless of underlying health conditions, suggesting that clinicians should recommend daily social interactions for all older individuals.

Read Full News

Latest News

The Obesity Paradox: High in Calories, Low in Nutrients

Beyond Laxatives: Emerging Ways to Manage Constipation

In this Medscape podcast, Dr Benjamin Levy interviews Dr Darren Brenner about modern constipation management, including pelvic floor dysfunction, motility testing, and nonpharmacologic therapies.

New Data Support Medication Switch in Select MS Patients

For patients experiencing increased rates of infection or adverse events on anti-CD20 therapy, switching to a less immunosuppressive option may be a safe option, data show.

Scotland Backs Bispecific Antibody for Refractory Myeloma

The SMC accepted talquetamab for relapsed and refractory multiple myeloma, offering eligible patients in Scotland a new option after multiple prior therapies.

Frontline Serplulimab Extends Survival in SCLC

Four-year follow-up from the ASTRUM-005 trial shows durable survival benefits with first-line serplulimab plus chemotherapy in extensive-stage SCLC.

Primary Care Anti-Dementia Med Prescribing Shows Disparities

Prescribing rates for anti-dementia medications in England are lower than expected, with notable disparities in prescribing based on patient-level characteristics.

Todays Updates

FDA Grants Emergency Approval for Over-the-counter Drug to Treat Screwworm in Pets

The U.S. Food and Drug Administration on Thursday authorized the emergency use of a generic over-the-counter tablet ⁠to treat infestations caused by the New World screwworm...

Highlights in Prostate Cancer From AUA 2026

Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.

New Imaging Agent Could Speed Detection of AD-Related Tau

A novel PET imaging agent identified AD-related tau earlier and in more patients than the currently used tracer, possibly speeding AD detection, a new study shows.

CMS Rule Misses Mark on CPAP Adherence

A Kaiser Permanente study shows some people who initially struggle with CPAP adherence still use the device at 1 year, suggesting CMS’ 90-day cutoff is too strict.

Good Outcomes with Ublituximab in First Real-World Study

Even though the real-world patients in a phase 4 study were older and heavier, ublituximab provided safety and tolerability at least comparable to that in 2 pivotal trials.

Organon Wins US Approval to Widen Use Of Arthritis Biosimilar Drug

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Ebola Testing Stalled in Three Congo Labs Due to Shortages, Says WHO

Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World ⁠Health Organization said, as the outbreak of the dangerous...

Todays Updates

FDA Grants Emergency Approval for Over-the-counter Drug to Treat Screwworm in Pets

The U.S. Food and Drug Administration on Thursday authorized the emergency use of a generic over-the-counter tablet ⁠to treat infestations caused by the New World screwworm...

Highlights in Prostate Cancer From AUA 2026

Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.

New Imaging Agent Could Speed Detection of AD-Related Tau

A novel PET imaging agent identified AD-related tau earlier and in more patients than the currently used tracer, possibly speeding AD detection, a new study shows.

CMS Rule Misses Mark on CPAP Adherence

A Kaiser Permanente study shows some people who initially struggle with CPAP adherence still use the device at 1 year, suggesting CMS’ 90-day cutoff is too strict.

Good Outcomes with Ublituximab in First Real-World Study

Even though the real-world patients in a phase 4 study were older and heavier, ublituximab provided safety and tolerability at least comparable to that in 2 pivotal trials.

Organon Wins US Approval to Widen Use Of Arthritis Biosimilar Drug

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Ebola Testing Stalled in Three Congo Labs Due to Shortages, Says WHO

Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World ⁠Health Organization said, as the outbreak of the dangerous...

Latest News

In this Medscape podcast, Dr Benjamin Levy interviews Dr Darren Brenner about modern constipation management, including pelvic floor dysfunction, motility testing, and nonpharmacologic therapies.

For patients experiencing increased rates of infection or adverse events on anti-CD20 therapy, switching to a less immunosuppressive option may be a safe option, data show.

The SMC accepted talquetamab for relapsed and refractory multiple myeloma, offering eligible patients in Scotland a new option after multiple prior therapies.

Four-year follow-up from the ASTRUM-005 trial shows durable survival benefits with first-line serplulimab plus chemotherapy in extensive-stage SCLC.

Prescribing rates for anti-dementia medications in England are lower than expected, with notable disparities in prescribing based on patient-level characteristics.

News All Time

Digital CBT May Help Cut Risk for Depression, Anxiety, EDs

Digital cognitive-behavioral therapy-guided self-help is linked to reduced risk for mental disorders such as depression and anxiety in college students, a new study shows.

OPTIMA Supports Therapy De-escalation in Breast Cancer

The 50-gene Prosigna assay can help guide chemotherapy decision-making, identifying patients aged 40 years or older who are unlikely to derive meaningful benefit from treatment.

Doppler Measures Spot Brain Risk in FGR

Middle cerebral artery Doppler and cerebroplacental ratio can help predict adverse neurologic outcomes in foetal growth restriction, supporting antenatal risk stratification.

CGRP Mab for Migraine Linked to Fracture Risk

CGRP monoclonal antibodies are associated with a higher odds of fracture in a large retrospective study, highlighting a potential safety signal that warrants further investigation.

Novel Tool Predicts Risk for Difficult-To-Treat Depression

A novel self-report tool may help identify patients with major depressive disorder at risk for difficult-to-treat depression before multiple treatment failures occur.

AI Model Captures Eosinophilic Esophagitis Missed by Codes

A large language model, when combined with standard diagnostic codes, may help identify more cases of eosinophilic esophagitis than diagnostic codes alone.

Canadian Physicians Fight the Good Fight on Social Media

Despite a lack of support from their community and a lot of mudslinging, some doctors take to social media out of a desire to educate and defend the vulnerable.

Cancer Crowdfunding and the Crippling Cost of Care

Faced with high medical bills and other expenses, people with cancer are increasingly turning to crowdfunding campaigns. But how much do these campaigns really help?

GLP-1 Drugs and Ischemic Optic Neuropathy: What to Know

Research has not shown a direct causation, but clinicians should be aware of the risks.

Do Vaginal Births With Related Procedures Mean More Opioids?

Patients who undergo vaginal delivery with associated procedures have a higher likelihood of receiving an opioid prescription at discharge.

Can DNA Methylation Tests Improve Triage in Cervical Cancer?

A meta-analysis reveals that DNA methylation markers are associated with high diagnostic accuracy for high-grade cervical intraepithelial neoplasia and cervical cancer.

APA Poll: US Anxiety Levels Continue to Climb in 2026

Anxiety levels are rising in the US over last year, driven mostly by current global events and expenses, along with AI concerns, the APA Mental Health Survey 2026 reports.

CVD Patients Stay on Aspirin Despite Negative Messages

Despite negative messages about aspirin, a survey finds that adults with atherosclerotic cardiovascular disease maintain regular use of the drug for secondary prevention.

Deep Dive: Is the Autism Definition Too Broad?

A category broad enough to capture every patient who benefits from ASD-informed care may leave the most vulnerable behind.

Can You Ban Anti-Vax Family From Rural Practice?

Ethicist Art Caplan discusses the case of a physician considering banning an anti-vax family from his practice during a measles outbreak.

Chasing Bigger Weight Loss Demands New Playbook

In what he calls the ‘Weight Loss Olympics,’ Robert Gabbay, MD, PhD, explains why the focus on the next generation of multiagonists must turn to targeted comorbidity-driven engineering.

Recommended News For You

Eliminating the SRC-3 gene in immune cells causes an efficient, long-lasting anti-cancer response.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

Brexpiprazole Safe, Effective in Early-Episode Schizophrenia

ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types

Targeted Combination Shows Promise in Metastatic Kidney Cancer

Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers

How artificial intelligence could significantly improve the prognosis for cancer patients.

Recommended Articles For You

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond 

Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies 

Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding 

Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Massachusetts nurses with brain tumors: Department of Public Health 'in communication' with Newton-Wellesley

2.

Novel probes to label macrophages associated with cancer progression using a selective dye

3.

Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC

4.

Study suggests exercise could reduce breast cancer recurrence

5.

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

1.

The Latest Research on Chronic Granulomatous Disease and Promising New Treatments 

2.

Everything You Need to Know About CA 19-9 and Cancer Diagnosis

3.

The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025

4.

Integrated Trends in Hematology for Modern Medicine

5.

Genetic Screening: A Game Changer in Cancer Prevention

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Current Scenario of Cancer- Q&A Session to Close the Gap

2.

Managing CNS diseases at the point of diagnosis in ALK + NSCLC

3.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

5.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot